The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

Q1 Wegovy sales rose 85% to DKK 17.36 billion ... In February 2025, Novo Nordisk submitted oral semaglutide 25 mg to the FDA, with the potential to be the first oral GLP-1 treatment for obesity.

Shares of Novo Nordisk jumped nearly 7% on Wednesday after it said sales of its blockbuster Wegovy weight loss drug ... "Following the U.S. FDA removal of semaglutide injectables from the FDA ...

Caremark negotiated an undisclosed lower net price for Wegovy over Zepbound on its standard formularies, offering savings on Novo Nordisk's drug to clients that opt into those plans. But ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If approved, it would be the first GLP-1 pill indicated for obesity ...

A. There is growing evidence that medications like semaglutide (Wegovy, Ozempic) can reduce drinking, even for people with alcohol problems (Journal of Clinical Investigation, March 6, 2025).

How Does Semaglutide Work for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic. Wegovy. Rybelsus. What do these medications have in common? They all contain ...

the maker of the weight-loss drug Wegovy. San Francisco-based Hims & Hers said the plan was to make obesity care “more accessible, more affordable and more connected” for Americans.

Around 63 per cent had reduced liver inflammation The trial, funded by drugmaker Novo Nordisk, included nearly 1,000 patients who had MASH and were given a weekly 2.4-milligram dose of semaglutide, ...

Notably, the authors did not know whether people who visited the hospital were taking Ozempic, Wegovy, or a copycat semaglutide prepared by pharmacists. Cohen said taking a compounded semaglutide ...